Rocket Lab has delivered a 780% return in under 14 months, validating my initial bullish thesis despite my personal decision ...

Regenxbio's RGX-121 gene therapy for Hunter syndrome is the main catalyst, with FDA approval targeted for February 2026.

Ukrianian soldiers are skeptical of proposals to hand over territory to Russia in exchange for peace, despite diplomatic ...

Q4 2025 Earnings Call Transcript September 2, 2025 Zscaler, Inc. beats earnings expectations. Reported EPS is $0.89, ...

Yahoo Finance is chronicling the latest news and updates on Trump's tariffs.

Yahoo Finance is chronicling the latest news and updates on Trump's tariffs.

This study illustrates a valuable application of BID-seq to bacterial RNA, allowing transcriptome-wide mapping of pseudouridine modifications across various bacterial species. The evidence presented ...